世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Myeloma Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3953 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法・その他薬剤、放射線、幹細胞移植、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・多発性骨髄腫治療の市場動向 ・企業の競争状況、市場シェア ・多発性骨髄腫治療の種類別市場規模（化学療法・その他薬剤、放射線、幹細胞移植、その他） ・多発性骨髄腫治療の用途別市場規模（病院、クリニック、その他） ・多発性骨髄腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・多発性骨髄腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・多発性骨髄腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多発性骨髄腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・多発性骨髄腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Janssen Biotech, Inc.、Bristol-Myers Squibb、Novartis AG、Bristol-Myers Squibb Company、Millennium Pharmaceuticals、Celgene Corporation、Kesios Therapeutics Limited、Amgene, Inc.、Genzyme Corporation、Juno Therapeutics） ・結論

Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.

Market Analysis and Insights: Global Multiple Myeloma Therapeutics Market
The global Multiple Myeloma Therapeutics market size is projected to reach US$ 55870 million by 2026, from US$ 27270 million in 2019, at a CAGR of 10.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Myeloma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Myeloma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Myeloma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Myeloma Therapeutics market.

Global Multiple Myeloma Therapeutics Scope and Market Size
Multiple Myeloma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Myeloma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy And Other Drugs
Radiation
Stem Cell Transplant
Other Supportive Treatments

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Janssen Biotech, Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene, Inc.
Genzyme Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy And Other Drugs
1.2.3 Radiation
1.2.4 Stem Cell Transplant
1.2.5 Other Supportive Treatments
1.3 Market by Application
1.3.1 Global Multiple Myeloma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Myeloma Therapeutics Market Perspective (2016-2027)
2.2 Multiple Myeloma Therapeutics Growth Trends by Regions
2.2.1 Multiple Myeloma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Myeloma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Myeloma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Myeloma Therapeutics Industry Dynamic
2.3.1 Multiple Myeloma Therapeutics Market Trends
2.3.2 Multiple Myeloma Therapeutics Market Drivers
2.3.3 Multiple Myeloma Therapeutics Market Challenges
2.3.4 Multiple Myeloma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Myeloma Therapeutics Players by Revenue
3.1.1 Global Top Multiple Myeloma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Myeloma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Myeloma Therapeutics Revenue
3.4 Global Multiple Myeloma Therapeutics Market Concentration Ratio
3.4.1 Global Multiple Myeloma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Myeloma Therapeutics Revenue in 2020
3.5 Multiple Myeloma Therapeutics Key Players Head office and Area Served
3.6 Key Players Multiple Myeloma Therapeutics Product Solution and Service
3.7 Date of Enter into Multiple Myeloma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Myeloma Therapeutics Breakdown Data by Type
4.1 Global Multiple Myeloma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Multiple Myeloma Therapeutics Breakdown Data by Application
5.1 Global Multiple Myeloma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Myeloma Therapeutics Market Size (2016-2027)
6.2 North America Multiple Myeloma Therapeutics Market Size by Type
6.2.1 North America Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Multiple Myeloma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Multiple Myeloma Therapeutics Market Size by Type (2016-2027)
6.3 North America Multiple Myeloma Therapeutics Market Size by Application
6.3.1 North America Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Multiple Myeloma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Multiple Myeloma Therapeutics Market Size by Application (2016-2027)
6.4 North America Multiple Myeloma Therapeutics Market Size by Country
6.4.1 North America Multiple Myeloma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Multiple Myeloma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Multiple Myeloma Therapeutics Market Size (2016-2027)
7.2 Europe Multiple Myeloma Therapeutics Market Size by Type
7.2.1 Europe Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Multiple Myeloma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Multiple Myeloma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Multiple Myeloma Therapeutics Market Size by Application
7.3.1 Europe Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Multiple Myeloma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Multiple Myeloma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Multiple Myeloma Therapeutics Market Size by Country
7.4.1 Europe Multiple Myeloma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Multiple Myeloma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Myeloma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Myeloma Therapeutics Market Size (2016-2027)
9.2 Latin America Multiple Myeloma Therapeutics Market Size by Type
9.2.1 Latin America Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Myeloma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Myeloma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Multiple Myeloma Therapeutics Market Size by Application
9.3.1 Latin America Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Myeloma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Myeloma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Multiple Myeloma Therapeutics Market Size by Country
9.4.1 Latin America Multiple Myeloma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Myeloma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Myeloma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Janssen Biotech, Inc.
11.1.1 Janssen Biotech, Inc. Company Details
11.1.2 Janssen Biotech, Inc. Business Overview
11.1.3 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Introduction
11.1.4 Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.1.5 Janssen Biotech, Inc. Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Multiple Myeloma Therapeutics Introduction
11.3.4 Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Details
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.5.5 Millennium Pharmaceuticals Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Details
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Multiple Myeloma Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.6.5 Celgene Corporation Recent Development
11.7 Kesios Therapeutics Limited
11.7.1 Kesios Therapeutics Limited Company Details
11.7.2 Kesios Therapeutics Limited Business Overview
11.7.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Introduction
11.7.4 Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.7.5 Kesios Therapeutics Limited Recent Development
11.8 Amgene, Inc.
11.8.1 Amgene, Inc. Company Details
11.8.2 Amgene, Inc. Business Overview
11.8.3 Amgene, Inc. Multiple Myeloma Therapeutics Introduction
11.8.4 Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.8.5 Amgene, Inc. Recent Development
11.9 Genzyme Corporation
11.9.1 Genzyme Corporation Company Details
11.9.2 Genzyme Corporation Business Overview
11.9.3 Genzyme Corporation Multiple Myeloma Therapeutics Introduction
11.9.4 Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.9.5 Genzyme Corporation Recent Development
11.10 Juno Therapeutics
11.10.1 Juno Therapeutics Company Details
11.10.2 Juno Therapeutics Business Overview
11.10.3 Juno Therapeutics Multiple Myeloma Therapeutics Introduction
11.10.4 Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2016-2021)
11.10.5 Juno Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy And Other Drugs
Table 3. Key Players of Radiation
Table 4. Key Players of Stem Cell Transplant
Table 5. Key Players of Other Supportive Treatments
Table 6. Global Multiple Myeloma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Multiple Myeloma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Multiple Myeloma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Multiple Myeloma Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Multiple Myeloma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Multiple Myeloma Therapeutics Market Share by Regions (2022-2027)
Table 12. Multiple Myeloma Therapeutics Market Trends
Table 13. Multiple Myeloma Therapeutics Market Drivers
Table 14. Multiple Myeloma Therapeutics Market Challenges
Table 15. Multiple Myeloma Therapeutics Market Restraints
Table 16. Global Multiple Myeloma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Multiple Myeloma Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Therapeutics as of 2020)
Table 19. Ranking of Global Top Multiple Myeloma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Multiple Myeloma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Multiple Myeloma Therapeutics Product Solution and Service
Table 23. Date of Enter into Multiple Myeloma Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Multiple Myeloma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Multiple Myeloma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Multiple Myeloma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Multiple Myeloma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Multiple Myeloma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Multiple Myeloma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Multiple Myeloma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Multiple Myeloma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Multiple Myeloma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Multiple Myeloma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Multiple Myeloma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Multiple Myeloma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Multiple Myeloma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Multiple Myeloma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Multiple Myeloma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Multiple Myeloma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Multiple Myeloma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Multiple Myeloma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Multiple Myeloma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Multiple Myeloma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Janssen Biotech, Inc. Company Details
Table 64. Janssen Biotech, Inc. Business Overview
Table 65. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Product
Table 66. Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Janssen Biotech, Inc. Recent Development
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Multiple Myeloma Therapeutics Product
Table 71. Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Novartis AG Company Details
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Multiple Myeloma Therapeutics Product
Table 76. Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Novartis AG Recent Development
Table 78. Bristol-Myers Squibb Company Company Details
Table 79. Bristol-Myers Squibb Company Business Overview
Table 80. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product
Table 81. Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Company Recent Development
Table 83. Millennium Pharmaceuticals Company Details
Table 84. Millennium Pharmaceuticals Business Overview
Table 85. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product
Table 86. Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Millennium Pharmaceuticals Recent Development
Table 88. Celgene Corporation Company Details
Table 89. Celgene Corporation Business Overview
Table 90. Celgene Corporation Multiple Myeloma Therapeutics Product
Table 91. Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Celgene Corporation Recent Development
Table 93. Kesios Therapeutics Limited Company Details
Table 94. Kesios Therapeutics Limited Business Overview
Table 95. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product
Table 96. Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Kesios Therapeutics Limited Recent Development
Table 98. Amgene, Inc. Company Details
Table 99. Amgene, Inc. Business Overview
Table 100. Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Amgene, Inc. Recent Development
Table 102. Genzyme Corporation Company Details
Table 103. Genzyme Corporation Business Overview
Table 104. Genzyme Corporation Multiple Myeloma Therapeutics Product
Table 105. Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Genzyme Corporation Recent Development
Table 107. Juno Therapeutics Company Details
Table 108. Juno Therapeutics Business Overview
Table 109. Juno Therapeutics Multiple Myeloma Therapeutics Product
Table 110. Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Juno Therapeutics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy And Other Drugs Features
Figure 3. Radiation Features
Figure 4. Stem Cell Transplant Features
Figure 5. Other Supportive Treatments Features
Figure 6. Global Multiple Myeloma Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Multiple Myeloma Therapeutics Report Years Considered
Figure 11. Global Multiple Myeloma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Multiple Myeloma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Multiple Myeloma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Multiple Myeloma Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Multiple Myeloma Therapeutics Market Share by Players in 2020
Figure 16. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Myeloma Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapeutics Revenue in 2020
Figure 18. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Multiple Myeloma Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Multiple Myeloma Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Multiple Myeloma Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Multiple Myeloma Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Multiple Myeloma Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Multiple Myeloma Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Multiple Myeloma Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Multiple Myeloma Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Multiple Myeloma Therapeutics Market Share by Region (2016-2027)
Figure 40. China Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Multiple Myeloma Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Multiple Myeloma Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Multiple Myeloma Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Multiple Myeloma Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Multiple Myeloma Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Multiple Myeloma Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Multiple Myeloma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Janssen Biotech, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 63. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 64. Celgene Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 65. Kesios Therapeutics Limited Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 66. Amgene, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 67. Genzyme Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 68. Juno Therapeutics Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---